Autoimmune Response to Proteasome Activator 28α in Patients with Connective Tissue Diseases

Journal of Rheumatology

Volumn 31, Issue 2, 2004, Pages 252-259

  Matsushita, Masakazu ^a,b   Takasaki, Yoshinari ^a   Takeuchi, Ken ^a   Yamada, Hirofumi ^a   Matsudaira, Ran ^a   Hashimoto, Hiroshi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Anti Ki antibody; Autoantibody; Proteasome activator 28 ; Proteasome activator 28 ; Sj gren's syndrome; Systemic lupus erythematosus

Indexed keywords

ANTIGEN; AUTOANTIBODY; COMPLEMENTARY DNA; CROSS REACTING ANTIBODY; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; KI ANTIBODY; KI ANTIGEN; PROTEASOME; PROTEASOME ACTIVATOR 28ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; AUTOIMMUNITY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATIC DISEASE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; CYSTEINE ENDOPEPTIDASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIENZYME COMPLEXES; MUSCLE PROTEINS; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; RECOMBINANT PROTEINS; SJOGREN'S SYNDROME;

EID: 0742270419     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Realini C, Dubiel W, Pratt G, Ferrel K, Rechsteiner M. Molecular cloning and expression of a g-interferon-inducible activator of the multicatalytic protease. J Biol Chem 1994;269:20727-32.
2. Ahn JY, Tanahashi N, Akiyama K, et al. Primary structures of two homologous subunits of PA28, a g-interferon-inducible protein activator of the 20S proteasome [letter]. FEBS Lett 1995;366:37-42.
3. Tanaka K, Chiba T. The proteasome: a protein-destroying machine. Genes Cells 1998;3:499-510.
4. Murata S, Kawahara H, Tohma S, Yamamoto K, Kasahara M, Nabeshima Y. Growth retardation in mice lacking the proteasome activator PA28g. J Biol Chem 1999;274:38211-5.
5. Tanahashi N, Murakami Y, Minami Y, Shimbara N, Hendil KB, Tanaka K. Hybrid proteasomes. J Biol Chem 2000;275:14336-45.
6. Whitby FG, Masters EI, Kramer L, et al. Structural basis for the activation of 20S proteasomes by 11S regulators. Nature 2000;408:115-20.
7. Tojo T, Kaburaki J, Hayakawa M, Okamoto T, Tomii M, Homma M. Precipitating antibody to a soluble nuclear antigen "Ki" with specificity for systemic lupus erythematosus. Ryumachi 1981;21 Suppl: 129-34.
8. Sakamoto M, Takasaki Y, Yamanaka K, Kodama A, Hashimoto H, Hirose S. Purification and characterization of Ki antigen and detection of anti-Ki antibody by enzyme-linked immunosorbent assay in patients with systemic lupus erythematosus. Arthritis Rheum 1989;32:1554-62.
9. Yamanaka K, Takasaki Y, Nishida Y, Shimada K, Shibata M, Hashimoto H. Detection and quantification of anti-Ki antibodies by enzyme-linked immunosorbent assay using recombinant Ki antigen. Arthritis Rheum 1992;35:667-71.
10. Bernstein RM, Morgan SH, Bunn CC, Gainey RC, Hughes GRV, Mathews MB. The SL autoantibody-antigen system: clinical and biochemical studies. Ann Rheum Dis 1986;45:353-8.
11. Harmon C, Peebles C, Tan EM. SL - a new precipitating system [abstract]. Arthritis Rheum 1981;24 Suppl:S122.
12. Nikaido T, Shimada K, Shibata M, et al. Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected in sera from patients with systemic lupus erythematosus. Clin Exp Immunol 1990;79:209-14.
13. Yano T, Takasaki Y, Takeuchi K, Hirokawa K, Yamanaka K, Hashimoto H. Anti-Ki antibodies recognize an epitope homologous with SV40 nuclear localization signal: clinical significance and reactivities in various immunoassays. Mod Rheumatol 2002;12:50-5.
14. Wocik C, Tanaka K, Paweletz N, Naab U, Wilk S. Proteasome activator (PA28) subunits, alpha, beta and gamma (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells. Eur J Cell Biol 1998;77:151-60.
15. Tanahashi N, Yokota K, Ahn JY, et al. Molecular properties of the proteasome activator PA28 family proteins and g-interferon regulation. Genes Cells 1997;2:195-211.
16. Wilk S, Chen EW, Magnusson PR. Properties of the nuclear proteasome activator PA28g (REG g). Arch Biochem Biophys 2000;383:265-71.
17. Realini C, Jensen CC, Zhang Z, et al. Characterization of recombinant REGa, REGβ, and REGg proteasome activators. J Biol Chem 1997;272:25483-92.
18. Feist E, Dörner T, Kuckelkorn U, Schmidtke G, Micheel B, Hiepe F. Proteasome a-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus. J Exp Med 1996;184:1313-8.
19. Feist E, Kuckelkorn U, Dörner T, Dönitz H, Scheffler S, Hiepe F. Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the a and β type. Arthritis Rheum 1999;42:697-702.
20. Feist E, Dörner T, Kuckelkorn U, Scheffler S, Burmester GR, Kloetzel PM. Diagnostic importance of anti-proteasome antibodies. Int Arch Allergy Immunol 2000;123:92-7.
21. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
22. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
23. Subcommittee for Scleroderma Criteria for the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
24. Fujibayashji H, Sugai S, Miyasaka N. Criteria for Sjögren's syndrome in Japan defined by the Research Committee on Autoimmune Diseases of the Ministry of Health and Welfare of Japan. 1999 annual report [Japanese]. Tokyo: Ministry of Health and Welfare of Japan; 1999:135.
25. Bohan A, Peter JB, Bowman RS, Pearson CM. A computer-assisted analysis of 157 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977;56:255-83.
26. Kasukawa R, Tojo T, Miyawaki S, et al. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue disease and antinuclear antibodies. Excerpta Medica International Congress Series 719. Amsterdam: Elsevier Science Publishers; 1987.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
28. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4.
29. Tan EM. Antinuclear antibodies: Diagnostic markers for autoimmune disease and probes for cell biology. Adv Immunol 1989;44:93-151.
30. Watanabe T, Tsuchida T, Kanda N, Mori K, Hayashi Y, Tamaki K. Anti-a-fodrin antibodies in Sjögren's syndrome and lupus erythematosus. Arch Dermatol 1999;135:535-9.
31. Kuwana M, Okano T, Ogawa Y, Kaburaki J, Kawami Y. Autoantibodies to the amino-terminal fragment of β-fodrin expressed in glandular epithelial cell in patients with Sjögren's syndrome. J Immunol 2001;167:5449-56.
32. Nordmark G, Rorsman F, Rönnblom L, et al. Autoantibodies to a-fodrin in primary Sjögren's syndrome and SLE detected by an in vitro transcription and translation assay. Clin Exp Rheumatol 2003;21:49-56.
33. Goodman-Snitkoff, Good FM, Berzofsky AJ, Mannino JR. Role of intrastructural/intermolecular help in immunization with peptide-phospholipid complexes. J Immunol 1991;147:410-5.
34. Tseng C-E, Chan EKL, Miranda E, Gross M, Di Donatio F, Buyon JP. The 52-kd protein as a target of intermolecular spreading of the immune response to components of the SS-A/Ro-SS-B/La complex. Arthritis Rheum 1997;40:936-44.
35. Takasaki Y, Kogure T, Takeuchi K, et al. Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiprotein complex involved in cell proliferation. J Immunol 2001;166:4780-7.
36. Brouwer R, Vree Egberts WT, Hengstman GJ, et al. Autoantibodies directed to novel components of the PM/Scl complex, the human exosome. Arthritis Res 2002;4:134-8.
37. Monneaux F, Muller S. Epitope spreading in systemic lupus erythematosus: Identification of triggering peptide sequences. Arthritis Rheum 2002;46:1430-8.
38. Kogure T, Takasaki Y, Takeuchi K, et al. Autoimmune responses to proliferating cell nuclear antigen multiprotein complexes involved in cell proliferation are strongly associated with their structure and biologic function in patients with systemic lupus erythematosus. Arthritis Rheum 2002;46:2946-56.
39. Töpfer F, Gordon T, McClusky J. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Natl Acad Sci USA 1995;92:875-9.